113 related articles for article (PubMed ID: 19954047)
1. [The clinical efficacy and safety of intravenous levofloxacin in the treatment of 4888 patients with bacterial infections: a multi-center trial].
Cooperation Group for Phase IV Clinical Study of Levofloxacin
Zhonghua Nei Ke Za Zhi; 2009 Jun; 48(6):492-6. PubMed ID: 19954047
[TBL] [Abstract][Full Text] [Related]
2. Prulifloxacin versus levofloxacin in the treatment of respiratory and urinary tract infections: a multicentre, double-blind, randomized controlled clinical trial.
Chen Y; Yang H; Lu G; Wu X; Huang W; Wu Y; Lv X; Wu G; Zhang G; Li Q; Sun Y
Chemotherapy; 2012; 58(3):249-56. PubMed ID: 22890091
[TBL] [Abstract][Full Text] [Related]
3. An open-label, double tympanocentesis study of levofloxacin therapy in children with, or at high risk for, recurrent or persistent acute otitis media.
Arguedas A; Dagan R; Pichichero M; Leibovitz E; Blumer J; McNeeley DF; Melkote R; Noel GJ
Pediatr Infect Dis J; 2006 Dec; 25(12):1102-9. PubMed ID: 17133154
[TBL] [Abstract][Full Text] [Related]
4. A phase III clinical trial of 0.5% levofloxacin ophthalmic solution versus 0.3% ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis.
Schwab IR; Friedlaender M; McCulley J; Lichtenstein SJ; Moran CT;
Ophthalmology; 2003 Mar; 110(3):457-65. PubMed ID: 12623805
[TBL] [Abstract][Full Text] [Related]
5. A multicenter, investigator-blinded, randomized comparison of oral levofloxacin and oral clarithromycin in the treatment of acute bacterial sinusitis.
Adelglass J; Jones TM; Ruoff G; Kahn JB; Wiesinger BA; Rielly-Gauvin K; Siu CO
Pharmacotherapy; 1998; 18(6):1255-63. PubMed ID: 9855324
[TBL] [Abstract][Full Text] [Related]
6. Open-label assessment of levofloxacin for the treatment of acute bacterial sinusitis in adults.
Sydnor TA; Kopp EJ; Anthony KE; LoCoco JM; Kim SS; Fowler CL
Ann Allergy Asthma Immunol; 1998 Apr; 80(4):357-62. PubMed ID: 9564988
[TBL] [Abstract][Full Text] [Related]
7. [A multi-center, randomized, controlled, double blind and double dummy clinical trial of antofloxacin hydrochloride tablet versus levofloxacin tablet for the treatment of acute bacterial infections].
Xiao YH; Cui H; Xue F; Huang WX; Xiu QY; Li DT; Chen P; Jia ZP; Wen AD; Yang GP; Mao GG
Zhonghua Nei Ke Za Zhi; 2011 Mar; 50(3):225-9. PubMed ID: 21600087
[TBL] [Abstract][Full Text] [Related]
8. [Preliminary clinical evaluations of panipenem-betamipron in the treatment of hematological malignancy infections].
Li JJ; Jia YQ; Cui X; Huang J; He C
Zhonghua Yi Xue Za Zhi; 2012 Feb; 92(7):452-5. PubMed ID: 22490964
[TBL] [Abstract][Full Text] [Related]
9. Community-Acquired Pneumonia Recovery in the Elderly (CAPRIE): efficacy and safety of moxifloxacin therapy versus that of levofloxacin therapy.
Anzueto A; Niederman MS; Pearle J; Restrepo MI; Heyder A; Choudhri SH;
Clin Infect Dis; 2006 Jan; 42(1):73-81. PubMed ID: 16323095
[TBL] [Abstract][Full Text] [Related]
10. Randomized, double-blind, comparative study of levofloxacin and ofloxacin in the treatment of complicated urinary tract infections.
Peng MY
J Microbiol Immunol Infect; 1999 Mar; 32(1):33-9. PubMed ID: 11561568
[TBL] [Abstract][Full Text] [Related]
11. [Prevention of peri-operative infection with levofloxacin in female patients undergoing surgery for stress urinary incontinence].
Cao DY; Zhu L; Wang JH; Zhang Y
Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(21):1485-7. PubMed ID: 18953856
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of Levofloxacin, Clarithromycin and Esomeprazol as first line triple therapy for Helicobacter pylori eradication in Middle East. Prospective, randomized, blind, comparative, multicenter study.
Assem M; El Azab G; Rasheed MA; Abdelfatah M; Shastery M
Eur J Intern Med; 2010 Aug; 21(4):310-4. PubMed ID: 20603042
[TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of oral levofloxacin 500 mg once-daily dosage for treatment of lower respiratory tract infections and urinary tract infections: a prospective multicenter study in China.
Zhang YY; Huang HH; Ren ZY; Zheng HG; Yu YS; Lü XJ; Xiao ZK; Yang HF; Xiu QY; Chen BY; Yue HM; Hao QL; Huang JA; Ma H; Xiao W; Guo DY; Si B; Sun SH; Zhang W; Li QH; Shen HH; Duan J; Li HY; Yao WZ; Gu JM; Xia QM; Ying KJ; Liu A; Yang HP; Shi MH; Sun TY; Ding GH; Wu GM
J Infect Chemother; 2009 Oct; 15(5):301-11. PubMed ID: 19856068
[TBL] [Abstract][Full Text] [Related]
14. Oral levofloxacin 500 mg once daily in the treatment of chronic bacterial prostatitis.
Naber KG; Roscher K; Botto H; Schaefer V
Int J Antimicrob Agents; 2008 Aug; 32(2):145-53. PubMed ID: 18571904
[TBL] [Abstract][Full Text] [Related]
15. Clinical efficacy and tolerability of levofloxacin in patients with liver disease: a prospective, non comparative, observational study.
Esposito S; Noviello S; Leone S; Ianniello F; Ascione T; Gaeta GB
J Chemother; 2006 Feb; 18(1):33-7. PubMed ID: 16572891
[TBL] [Abstract][Full Text] [Related]
16. Levofloxacin versus clarithromycin in COPD exacerbation: focus on exacerbation-free interval.
Lode H; Eller J; Linnhoff A; Ioanas M;
Eur Respir J; 2004 Dec; 24(6):947-53. PubMed ID: 15572537
[TBL] [Abstract][Full Text] [Related]
17. Levofloxacin vs. ciprofloxacin plus phenethicillin for the prevention of bacterial infections in patients with haematological malignancies.
Timmers GJ; Simoons-Smit AM; Leidekker ME; Janssen JJ; Vandenbroucke-Grauls CM; Huijgens PC
Clin Microbiol Infect; 2007 May; 13(5):497-503. PubMed ID: 17263835
[TBL] [Abstract][Full Text] [Related]
18. [Levofloxacin-based triple therapy for first-line Helicobacter pylori eradication treatment: a multi-central, randomized, controlled clinical study].
Cheng H; Hu FL; Zhang GX; Shi RH; Du YQ; Li ZS; Han W; Li YQ; Wu QD; Qian KD
Zhonghua Yi Xue Za Zhi; 2010 Jan; 90(2):79-82. PubMed ID: 20356486
[TBL] [Abstract][Full Text] [Related]
19. Treatment of chronic bacterial prostatitis with levofloxacin and ciprofloxacin lowers serum prostate specific antigen.
Schaeffer AJ; Wu SC; Tennenberg AM; Kahn JB
J Urol; 2005 Jul; 174(1):161-4. PubMed ID: 15947609
[TBL] [Abstract][Full Text] [Related]
20. Once-daily oral gatifloxacin versus oral levofloxacin in treatment of uncomplicated skin and soft tissue infections: double-blind, multicenter, randomized study.
Tarshis GA; Miskin BM; Jones TM; Champlin J; Wingert KJ; Breen JD; Brown MJ
Antimicrob Agents Chemother; 2001 Aug; 45(8):2358-62. PubMed ID: 11451697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]